Literature DB >> 22436956

Prehospital epinephrine use and survival among patients with out-of-hospital cardiac arrest.

Akihito Hagihara1, Manabu Hasegawa, Takeru Abe, Takashi Nagata, Yoshifumi Wakata, Shogo Miyazaki.   

Abstract

CONTEXT: Epinephrine is widely used in cardiopulmonary resuscitation for out-of-hospital cardiac arrest (OHCA). However, the effectiveness of epinephrine use before hospital arrival has not been established.
OBJECTIVE: To evaluate the association between epinephrine use before hospital arrival and short- and long-term mortality in patients with cardiac arrest. DESIGN, SETTING, AND PARTICIPANTS: Prospective, nonrandomized, observational propensity analysis of data from 417 188 OHCAs occurring in 2005-2008 in Japan in which patients aged 18 years or older had an OHCA before arrival of emergency medical service (EMS) personnel, were treated by EMS personnel, and were transported to the hospital. MAIN OUTCOME MEASURES: Return of spontaneous circulation before hospital arrival, survival at 1 month after cardiac arrest, survival with good or moderate cerebral performance (Cerebral Performance Category [CPC] 1 or 2), and survival with no, mild, or moderate neurological disability (Overall Performance Category [OPC] 1 or 2).
RESULTS: Return of spontaneous circulation before hospital arrival was observed in 2786 of 15,030 patients (18.5%) in the epinephrine group and 23,042 of 402,158 patients (5.7%) in the no-epinephrine group (P < .001); it was observed in 2446 (18.3%) and 1400 (10.5%) of 13,401 propensity-matched patients, respectively (P < .001). In the total sample, the numbers of patients with 1-month survival and survival with CPC 1 or 2 and OPC 1 or 2, respectively, were 805 (5.4%), 205 (1.4%), and 211 (1.4%) with epinephrine and 18,906 (4.7%), 8903 (2.2%), and 8831 (2.2%) without epinephrine (all P <.001). Corresponding numbers in propensity-matched patients were 687 (5.1%), 173 (1.3%), and 178 (1.3%) with epinephrine and 944 (7.0%), 413 (3.1%), and 410 (3.1%) without epinephrine (all P <.001). In all patients, a positive association was observed between prehospital epinephrine and return of spontaneous circulation before hospital arrival (adjusted odds ratio [OR], 2.36; 95% CI, 2.22-2.50; P < .001). In propensity-matched patients, a positive association was also observed (adjusted OR, 2.51; 95% CI, 2.24-2.80; P < .001). In contrast, among all patients, negative associations were observed between prehospital epinephrine and long-term outcome measures (adjusted ORs: 1-month survival, 0.46 [95% CI, 0.42-0.51]; CPC 1-2, 0.31 [95% CI, 0.26-0.36]; and OPC 1-2, 0.32 [95% CI, 0.27-0.38]; all P < .001). Similar negative associations were observed among propensity-matched patients (adjusted ORs: 1-month survival, 0.54 [95% CI, 0.43-0.68]; CPC 1-2, 0.21 [95% CI, 0.10-0.44]; and OPC 1-2, 0.23 [95% CI, 0.11-0.45]; all P < .001).
CONCLUSION: Among patients with OHCA in Japan, use of prehospital epinephrine was significantly associated with increased chance of return of spontaneous circulation before hospital arrival but decreased chance of survival and good functional outcomes 1 month after the event.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22436956     DOI: 10.1001/jama.2012.294

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  107 in total

Review 1.  Cardiopulmonary resuscitation and management of cardiac arrest.

Authors:  Jerry P Nolan; Jasmeet Soar; Volker Wenzel; Peter Paal
Journal:  Nat Rev Cardiol       Date:  2012-06-05       Impact factor: 32.419

Review 2.  Novelties in pharmacological management of cardiopulmonary resuscitation.

Authors:  Jason A Bartos; Demetris Yannopoulos
Journal:  Curr Opin Crit Care       Date:  2013-10       Impact factor: 3.687

3.  Cardiac resuscitation: Epinephrine to treat cardiac arrest--a double-edged sword.

Authors:  Hans-Richard Arntz; Jan Breckwoldt
Journal:  Nat Rev Cardiol       Date:  2012-05-15       Impact factor: 32.419

4.  The aging population and future demand for emergency ambulances in Japan.

Authors:  Akihito Hagihara; Manabu Hasegawa; Yukako Hinohara; Takeru Abe; Midori Motoi
Journal:  Intern Emerg Med       Date:  2013-05-25       Impact factor: 3.397

5.  Higher achieved mean arterial pressure during therapeutic hypothermia is not associated with neurologically intact survival following cardiac arrest.

Authors:  Michael N Young; Ryan D Hollenbeck; Jeremy S Pollock; Jennifer L Giuseffi; Li Wang; Frank E Harrell; John A McPherson
Journal:  Resuscitation       Date:  2014-12-22       Impact factor: 5.262

6.  Vasopressors, antiarrhythmics, oxygen, and intubation in out-of-hospital cardiac arrest: possibly less is more.

Authors:  Claudio Sandroni; Markus B Skrifvars; Jasmeet Soar
Journal:  Intensive Care Med       Date:  2019-08-20       Impact factor: 17.440

7.  Rethinking the role of epinephrine in cardiac arrest: the PARAMEDIC2 trial.

Authors:  Julianna Jung; Julie Rice; Sharon Bord
Journal:  Ann Transl Med       Date:  2018-12

8.  Research progress of pre-hospital emergency during 2000-2020: a bibliometric analysis.

Authors:  Li Xu; Fen Tang; Yunyun Wang; Qi Cai; Shuhui Tang; Demeng Xia; Xianghua Xu; Xiaoying Lu
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

Review 9.  The present and future of cardiac arrest care: international experts reach out to caregivers and healthcare authorities.

Authors:  Jerry P Nolan; Robert A Berg; Clifton W Callaway; Laurie J Morrison; Vinay Nadkarni; Gavin D Perkins; Claudio Sandroni; Markus B Skrifvars; Jasmeet Soar; Kjetil Sunde; Alain Cariou
Journal:  Intensive Care Med       Date:  2018-06-02       Impact factor: 17.440

10.  Association Between Therapeutic Hypothermia and Outcomes in Patients with Non-shockable Out-of-Hospital Cardiac Arrest Developed After Emergency Medical Service Arrival (SOS-KANTO 2012 Analysis Report).

Authors:  Minoru Yoshida; Toru Yoshida; Yoshihiro Masui; Shigeki Fujitani; Yasuhiko Taira; Nobuya Kitamura; Yoshio Tahara; Atsushi Sakurai; Naohiro Yonemoto; Ken Nagao; Arino Yaguchi; Naoto Morimura
Journal:  Neurocrit Care       Date:  2019-04       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.